Evaluating the Effectiveness of Personalized Medicine With Software

Area of Science:

• Biostatistics
• Clinical Informatics
• Translational Medicine

Background:

• Personalized medicine aims to tailor treatments to individual patients for optimal outcomes.
• A key barrier to personalized medicine adoption is the lack of robust methods to evaluate its effectiveness against standard care.
• Quantifying the 'improvement' offered by personalized strategies over conventional approaches remains a challenge.

Purpose of the Study:

• To introduce methodological advancements for assessing personalized medicine effectiveness.
• To provide an accessible, open-source software tool, the R package "Personalized Treatment Evaluator" (PTE), for evaluating treatment personalization.
• To extend existing methodologies for improvement assessment to binary and survival endpoints.

Main Methods:

• The "Personalized Treatment Evaluator" (PTE) R package utilizes data from single-stage randomized trials.
• It accepts continuous, incidence, or survival endpoints and user-defined functional forms for treatment models.
• Out-of-sample inference is performed using bootstrapping on unseen data to estimate confidence intervals for improvement.

Main Results:

• The PTE software enables practitioners to evaluate the out-of-sample improvement of personalized medicine strategies.
• The methodology supports various endpoint types, including binary and survival data.
• Demonstrated promise on simulated data and a real-world depression treatment trial.

Conclusions:

• The developed methodology and PTE software offer a practical solution for evaluating personalized medicine effectiveness.
• This tool empowers clinicians to rigorously assess if personalized treatments outperform standard care.
• Facilitates wider adoption of personalized medicine by providing a clear measure of clinical improvement.